[go: up one dir, main page]

TR201713326A2 - Rivaroksaban İçeren Formülasyonlar İçin Üretim Yöntemi - Google Patents

Rivaroksaban İçeren Formülasyonlar İçin Üretim Yöntemi Download PDF

Info

Publication number
TR201713326A2
TR201713326A2 TR2017/13326A TR201713326A TR201713326A2 TR 201713326 A2 TR201713326 A2 TR 201713326A2 TR 2017/13326 A TR2017/13326 A TR 2017/13326A TR 201713326 A TR201713326 A TR 201713326A TR 201713326 A2 TR201713326 A2 TR 201713326A2
Authority
TR
Turkey
Prior art keywords
formulations containing
production method
containing rivaroxaban
formulations
rivaroxaban
Prior art date
Application number
TR2017/13326A
Other languages
English (en)
Inventor
Ünlü Serdar
Şahi̇n Yasemi̇n
Muhi̇bbi̇ Işik Murat
Soyer Can Okşan
Kara Gökşen
Original Assignee
Ali Raif Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ali Raif Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Ali Raif Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2017/13326A priority Critical patent/TR201713326A2/tr
Publication of TR201713326A2 publication Critical patent/TR201713326A2/tr

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Bu buluş rivaroksaban veya farmasötik olarak kabul edilebilir bir tuzunu içeren oral farmasötik formülasyonlara, bu formülasyonların üretim yöntemine ve bu yöntemle üretilen formülasyonların tromboembolik hastalıkların önlenmesinde ve/veya tedavi edilmesinde kullanılmasına ilişkindir.
TR2017/13326A 2017-09-11 2017-09-11 Rivaroksaban İçeren Formülasyonlar İçin Üretim Yöntemi TR201713326A2 (tr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2017/13326A TR201713326A2 (tr) 2017-09-11 2017-09-11 Rivaroksaban İçeren Formülasyonlar İçin Üretim Yöntemi

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/13326A TR201713326A2 (tr) 2017-09-11 2017-09-11 Rivaroksaban İçeren Formülasyonlar İçin Üretim Yöntemi

Publications (1)

Publication Number Publication Date
TR201713326A2 true TR201713326A2 (tr) 2019-03-21

Family

ID=67979881

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2017/13326A TR201713326A2 (tr) 2017-09-11 2017-09-11 Rivaroksaban İçeren Formülasyonlar İçin Üretim Yöntemi

Country Status (1)

Country Link
TR (1) TR201713326A2 (tr)

Similar Documents

Publication Publication Date Title
MX2024010140A (es) Nuevos metodos.
NZ762034A (en) Human plasma kallikrein inhibitors
MX380147B (es) Formas de dosificacion de ruxolitinib de liberacion sostenida.
CY1122024T1 (el) Ενωσεις αναστολης σηματοδοτησης μονοπατιου notch
EA201691481A1 (ru) ИНГИБИТОРЫ C5a ДЛЯ ЛЕЧЕНИЯ ВИРУСНОЙ ПНЕВМОНИИ
UA116999C2 (uk) Виділене антитіло до гемаглютиніну та фармацевтична композиція, що його містить
MA39765A (fr) Formulation pharmaceutique d'un inhibiteur de la kinase pan-raf, ses procédés de préparation, et procédés d'utilisation
TR201821116A2 (tr) POSAKONAZOL İÇEREN FARMASÖTİK BİLEŞİMLER ve ÜRETİM YÖNTEMİ
EA201692111A1 (ru) Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний
MX387731B (es) Composiciones farmacéuticas orales de mesalazina.
TR201819805T4 (tr) Flavaglin türevleri̇.
MX385687B (es) Inhibidores de calicreína plasmática humana.
EA201791009A1 (ru) Композиции, содержащие циклоспорин
JOP20190049A1 (ar) مثبطات دوبامين-b-هيدروكسيلاز
EA201790830A1 (ru) Ингибиторы альдостеронсинтазы
EA201692020A1 (ru) Пролекарственные средства янтарной кислоты для применения в лечении лактоацидоза или индуцируемого лекарственными средствами побочного действия вследствие связанных с комплексом i нарушений окислительного фосфорилирования в митохондриях
EP3564224A3 (en) Crystalline form of vortioxetine hydrobromide as antidepressant drug
TR201717703A2 (tr) Api̇ksaban formülasyonlari
PH12016502568A1 (en) Novel heterocyclic compound
CY1123394T1 (el) Φαρμακευτικη συνθεση
EA202090913A1 (ru) Композиция таблеток с модифицированным высвобождением, содержащая мирабегрон
EA201991286A1 (ru) Твердая фармацевтическая композиция для перорального применения, содержащая тенофовир и эмтрицитабин
EA201892842A1 (ru) Фармацевтические композиции, включающие сафинамид
PH12016502480A1 (en) Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases
PH12020500045A1 (en) Novel composition of enzalutamide oral dosage form and method of manufacturing thereof